Sildenafil (Viagra) associated anterior ischemic optic neuropathy

Archives of Ophthalmology

Volumn 118, Issue 2, 2000, Pages 291-292

  Egan, Robert ^a   Pomeranz, Howard ^b  

^a CASEY EYE INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; SILDENAFIL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLON CROHN DISEASE; COMORBIDITY; ERECTILE DYSFUNCTION; HUMAN; ISCHEMIA; MALE; OPTIC NERVE DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; TRANSURETHRAL RESECTION; VISUAL IMPAIRMENT;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; HUMANS; IMPOTENCE, VASCULOGENIC; MALE; MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; VISUAL FIELDS;

EID: 0033966053     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Goldstein I, Lue TE, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction: Sildenafil Study Group [published correction appears in N Engl J Med. 1998;59]. N Engl J Med. 1998;338:1347-1404.
2. Vobig MA, Klotz T, Staak M, Bartz-Schmidt KU, Engelmann U, Walter P. Retinal side-effects of sildenafil [letter]. Lancet. 1999;353:375.
3. Donahue SP, Taylor RJ. Pupil-sparing third nerve palsy associated with sildenafil citrate (Viagra). Am J Ophthalmol. 1998;126:476-477.
4. FDA Talk Paper. Pfizer updates Viagra labeling. Food and Drug Administration Web site. Available at: http://www.fda.gov/bbs/topics/ANSWERS/ ANS00926.html. Accessed May 10, 1999.